Journal
CELL METABOLISM
Volume 20, Issue 1, Pages 183-190Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2014.04.018
Keywords
-
Categories
Funding
- Intramural Research Program of the NIH, National Institute on Aging
- Office of Dietary Supplements, NIH
- National Heart, Lung, and Blood Institute [HL107361]
- NIH/National Center for Complementary and Alternative Medicine (NCCAM) [AT006526]
Ask authors/readers for more resources
Central arterial wall stiffening, driven by a chronic inflammatory milieu, accompanies arterial diseases, the leading cause of cardiovascular (CV) morbidity and mortality in Western society. An increase in central arterial wall stiffening, measured as an increase in aortic pulse wave velocity (PWV), is a major risk factor for clinical CV disease events. However, no specific therapies to reduce PWV are presently available. In rhesus monkeys, a 2 year diet high in fat and sucrose (HFS) increases not only body weight and cholesterol, but also induces prominent central arterial wall stiffening and increases PWV and inflammation. The observed loss of endothelial cell integrity, lipid and macrophage infiltration, and calcification of the arterial wall were driven by genomic and proteomic signatures of oxidative stress and inflammation. Resveratrol prevented the HFS-induced arterial wall inflammation and the accompanying increase in PWV. Dietary resveratrol may hold promise as a therapy to ameliorate increases in PWV.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available